Shanghai Historical Income Statement
| 688193 Stock | 42.00 0.94 2.29% |
Historical analysis of Shanghai Rendu income statement accounts such as Interest Income of 9.2 M, Selling General Administrative of 109.5 M or Total Revenue of 244.1 M can show how well Shanghai Rendu Biotechnology performed in making a profits. Evaluating Shanghai Rendu income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shanghai Rendu's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Shanghai Rendu Biote latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shanghai Rendu Biote is a good buy for the upcoming year.
Shanghai |
About Shanghai Income Statement Analysis
Shanghai Rendu Biote Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shanghai Rendu shareholders. The income statement also shows Shanghai investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Shanghai Rendu Income Statement Chart
Total Revenue
Total revenue comprises all receipts Shanghai Rendu Biote generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Shanghai Rendu Biotechnology minus its cost of goods sold. It is profit before Shanghai Rendu operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Most accounts from Shanghai Rendu's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shanghai Rendu Biote current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Rendu Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Shanghai Rendu's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 9.2 M, whereas Tax Provision is projected to grow to (3.3 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 2.0M | 4.2M | 8.7M | 9.2M | Net Interest Income | 1.7M | 3.8M | 8.3M | 8.7M |
Shanghai Rendu income statement Correlations
Click cells to compare fundamentals
Shanghai Rendu Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Rendu Biote Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shanghai Rendu shareholders. The income statement also shows Shanghai investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).